Zegenex Secures Social-Impact Investment from Richard King Mellon Foundation.
$215,000 investment to drive formulation optimization and preclinical testing for Zegen-15, a first-of-its-kind therapy for chronic wounds.
PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors.
Click here for more information.
Read the Entire Article
A customized collection of news from foundations from around the Web.

In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.